Search Results
Results found for "Montana Molecular"
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular
- Dr. Bruno Giros | Dr. GPCR Ecosystem
Giros' lab investigates how molecular changes at the nerve synapse might impact integrated behavior and
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology His research aimed at understanding molecular mechanism through which rare genetic variation may lead
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Javitch1,2 1Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University , New York, NY 10032; 2Division of Molecular Therapeutics, New York State Psychiatric Institute, New
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
This project involves molecular pharmacology in cell models to determine binding sites and mechanisms Clements' work is primarily focused on translational developments of small molecule therapeutics, and
- irreversible drugs post 2 | Dr. GPCR Ecosystem
High-affinity molecules can get trapped at the periphery of a tumor, never reaching the core. Get it wrong, and the best molecule on paper stalls in development.
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky was awarded a B.S. with honors in Molecular and Cellular Biology and Psychology from The University
- 🚨 Exciting Opportunity for Professionals in Drug Development! 🚨 Register today for a one-of-a-kind online course at Dr. GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 ⏰ Time: Thursdays, 10:00 AM - 11:30 AM (EST) This advanced course is essential for anyone working in drug development and focuses on: The essentials of new drug development Key pharmacokinetic elements (absorption, distribution, clearance) Hepatic metabolism and the Cytochrome P450 system Drug safety and toxicology (including drug-drug interactions) And much more! Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules to life. 🚨 Only 25 spots available — register now! 💡 This is a great opportunity for both academia and industry professionals. Sessions will be live, and you’ll also have 1:1 discussion time with the instructor. Full PDFs of the slides will be available! 🔗 https://buff.ly/lVEcRUc #GPCR #DrugDevelopment #Pharmacokinetics #TherapeuticDrugs #OnlineCourse #DrGPCRUniversity #PharmaceuticalIndustry | Dr. GPCR Ecosystem
into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
Michelle earned her PhD in Molecular Pharmacology at Monash University, then trained in single-cell biology
- Dr. Stephane Angers | Dr. GPCR Ecosystem
His pioneer work led to the development of novel antibody molecules blocking and activating the Wnt pathway ModMab Therapeutics , and AntlerA Therapeutics , which are pursuing the clinical development of these molecules
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Single-Molecule Insights into GPCR Conformational Landscapes Rajan Lamichhane Discovery of CCR8 Antagonist Lilly and Company Postdoctoral Posit ion And PhD Position - Autonomous University of Barcelona GPCR Molecular into GPCR Conformational Landscapes Covalent functionalization of G protein-coupled receptors by small molecular probes A deadly taste: linking bitter taste receptors and apoptosis Molecular roles in membrane receptor Structural and Molecular Insights into GPCR Function Structural insights into prolactin-releasing peptide
- A GPCR imaging breakthrough that didn’t start in a grant proposal | Dr. GPCR Ecosystem
Johannes Broichhagen, was asked if he could synthesize a molecule “when you’re back in Munich.”
- Weekly News October 16 | Dr. GPCR Ecosystem
Weekly News October 16 Published on October 16, 2025 Category GPCR Weekly News Enzymes decide which molecules
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
Lessons from Molecules and Mentors He draws inspiration from scientific complexity and colleagues like “What fascinates me is how the same molecule behaves differently depending on one amino acid.” He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general
- Steve McCloskey | Dr. GPCR Ecosystem
solutions for Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule
- Courses (All) - Premium | Dr. GPCR Ecosystem
Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization of Candidate Molecules Lecture 1: GPCR Project Initiation and Design for Discovery of New Molecules Lecture 2: Drug Affinity
- Our History | Dr. GPCR Ecosystem
Jun 2023 — Featured Talk Molecular Pharmacology GRC and GRS in Switzerland.
- ama session sept 18 post 1 | Dr. GPCR Ecosystem
Precision in early decisions determines whether your molecule moves forward or stalls.
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
Slosky was awarded a B.S. with honors in Molecular and Cellular Biology and Psychology from The University
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think “As scientists, we know how to make molecules.
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
translating knowledge generated into the selection of targets, screening, and identification of small molecule
- Dr. Samuel Hoare | Dr. GPCR Ecosystem
newly-emerging pharmacology concepts, enabling them to be applied by project teams in optimizing new molecules
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
s fascinated by transgenerational epigenetics — how parental pain, diet, or drug exposure can leave molecular
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule Junior associate position and a PhD/post-doc level position Postdoctoral Position And PhD Position GPCR Molecular interact in epidermal keratinocytes and regulate cell motility The regenerative wound healing effects and molecular consumption Reviews, GPCRs, and more How Ligands Achieve Biased Signaling toward Arrestins Structural and Molecular
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Christian Baron studying bacterial secretion systems, I joined the molecular pharmacology laboratory
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
agonism, and incorporates computational and mathematical modelling, structural and chemical biology, molecular























